Table 2.
Record Type | N (records) | % of patients with 0 records |
N (patients with ≥1 record) |
Mean # of records/ patienta |
Percentilea | ||
---|---|---|---|---|---|---|---|
5th | 50th | 95th | |||||
Condition/Diagnosis | 66,640,582 | 2% | 1,386,116 | 48 | 3 | 25 | 168 |
Body Measurements | |||||||
Blood pressureb | 28,178,774 | 17% | 1,166,407c | 12 | 1 | 7 | 39 |
BMI | 11,444,904 | 35% | 922,179 | 12 | 1 | 8 | 39 |
Laboratory Results | |||||||
HbA1c | 471,334 | 83% | 236,320 | 2 | 1 | 1 | 5 |
Fasting plasma glucose | 76,255 | 98% | 32,332 | 2 | 1 | 1 | 8 |
Random glucose | 2,882,622 | 59% | 584,526 | 5 | 1 | 3 | 15 |
High-density lipoprotein | 1,429,156 | 65% | 489,356 | 3 | 1 | 2 | 8 |
Non-high-density lipoprotein | 1,303,719 | 66% | 474,663 | 3 | 1 | 2 | 8 |
Triglycerides | 1,407,124 | 64% | 503,075 | 3 | 1 | 2 | 8 |
Other labsd | 48,773,962 | 28% | 1,013,770 | 48 | 1 | 14 | 239 |
Medications | |||||||
Drug - speciale | 1,095,402 | 64% | 508,994 | 2 | 1 | 2 | 5 |
Drug - otherf | 13,352,367 | 8% | 1,300,717 | 10 | 1 | 7 | 30 |
Proceduresg | 24,394,282 | 25% | 1,062,867 | 23 | 1 | 11 | 85 |
Referrals | |||||||
Nutrition/Exercise Counseling | 275,413 | 93% | 106,466 | 3 | 1 | 1 | 7 |
Health Behavior Intervention/Risk Factor Reduction | 190,792 | 95% | 68,186 | 3 | 1 | 1 | 10 |
BMI = body mass index; HbA1c = hemoglobin A1c.
Mean and percentiles are calculated for patients with at least one record of the specified type.
There is not complete correspondence between systolic and diastolic blood pressure measurements. However, the statistics displayed here match for both systolic and diastolic measurements. Of the 28,178,774 blood pressure records, 14,148,706 (50.2%) are diastolic and 14,030,068 (49.8%) are systolic.
There are fewer patients with at least one systolic blood pressure measurement, 1,165,562.
Other labs include laboratory measurements of blood, serum, and urine, including blood cell counts, blood chemistry, and markers of liver and kidney function such as alanine aminotransferase, aspartate aminotransferase, and estimated glomerular filtration rate, and numerous other measurements.
Medications of special interest include antidiabetics, lipid lowering medications, and antihypertensive medications.
The top fifteen other medications are ibuprofen 800 mg, omeprazole 40 mg, fluticasone propionate 0.05 mg, azithromycin 250 mg, ibuprofen 600 mg, zolpidem tartrate 5 mg, omeprazole 20 mg, naproxen 500 mg, gabapentin, prednisone 20 mg, oxycodone hcl, levothyroxine sodium, ondansetron 4 mg, aspirin 500 mg, acetaminophen 500 mg/hydrocodone bitartrate 5 mg. Each represents <1% of all records.
Procedures are medical procedures such as ultrasounds and colonoscopies.